Adaptive Biotechnologies Corporation ADPT
Set alert
26.01 USD +0.95 +3.79%
As of Nov 3, 11:35 AM ET
25.33 Day range 26.46
12.00 52-week range 30.74
- YTD
- +60.16%
- 1 year
- +50.00%
- Open
- 25.46
- Prev close
- 25.06
- Mkt cap
- 4.16B
- Vol
- 335.05K
- Avg vol
- 2.17M
- EPS
- -0.41
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 25.33
- High
- 26.46
- Forward P/E
- -139.00
- Beta
- 2.15
- Short ratio
- 4.56
- Inst. own
- 99.03%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 26.38
- 200-d avg
- 19.60
- 1y target
- 30.21
MAX chart
Events in this range
- Aug 5, 2025Earnings: -0.17; estimate -0.24; surprise 29.17%
- Nov 6, 2025Earnings: 0.06; estimate -0.18; surprise 133.33%
- Feb 5, 2026Earnings: -0.09; estimate -0.19; surprise 52.63%
- May 5, 2026Earnings: -0.13; estimate -0.16; surprise 18.75%
- Jul 28, 2026Earnings: -0.25; estimate -0.13361; surprise -87.11%
- Aug 4, 2026Rating: Piper Sandler · Overweight → Overweight
- Sep 22, 2026Rating: BTIG · Buy → Buy
- Sep 29, 2026Rating: Goldman Sachs · — → Buy
- Oct 1, 2026Rating: Guggenheim · Buy → Buy
- Oct 13, 2026Rating: Morgan Stanley · Equal-Weight → Equal-Weight
- Oct 13, 2026Rating: TD Cowen · Buy → Buy
Signals (144)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 26, 2026 | 1 week ago |
| SMA: Bearish | Oct 12, 2026 | 3 weeks ago |
| MACD: Sell Signal | Oct 12, 2026 | 3 weeks ago |
| RSI: Overbought | Sep 14, 2026 | 1 month ago |
| RSI: Overbought | Aug 3, 2026 | 3 months ago |
| RSI: Overbought | Jul 13, 2026 | 3 months ago |
| SMA: Bullish | Jun 1, 2026 | 5 months ago |
| MACD: Buy Signal | Jun 1, 2026 | 5 months ago |
| SMA: Bullish | May 18, 2026 | 5 months ago |
| SMA: Bearish | May 4, 2026 | 6 months ago |
| SMA: Bullish | Apr 27, 2026 | 6 months ago |
| SMA: Bearish | Apr 20, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| SMA: Bearish | Mar 2, 2026 | 8 months ago |
| SMA: Bullish | Feb 23, 2026 | 8 months ago |
| SMA: Bearish | Feb 16, 2026 | 8 months ago |
| SMA: Bearish | Feb 2, 2026 | 9 months ago |
| SMA: Bullish | Jan 12, 2026 | 9 months ago |
| SMA: Bearish | Dec 29, 2025 | 10 months ago |
| SMA: Bullish | Dec 15, 2025 | 10 months ago |
Newest 20 of 144.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 30.21 +16.2% upside
Now 26.01
- Target (low)
- 21.00
- Target (mean)
- 30.21
- Target (high)
- 35.00
Ratings (0m) 8 8 buy · 0 hold · 0 sell
- Strong buy2
- Buy6
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 8
- 1 month ago 9
- 2 months ago 8
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.09552 | -0.11 – -0.08 | 0.06 | -259.2% | 71.60M | -23.8% | 7 |
| Next quarter | -0.06409 | -0.08 – -0.04 | -0.09 | +28.8% | 79.29M | +10.6% | 7 |
| Current year | -0.54243 | -0.57 – -0.51 | -0.39 | -39.1% | 293.25M | +5.9% | 7 |
| Next year | -0.18029 | -0.32 – -0.01 | -0.54243 | +66.8% | 360.14M | +22.8% | 7 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 13, 2026 | TD Cowen | Maintained | Buy | Buy |
| Oct 13, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Oct 1, 2026 | Guggenheim | Maintained | Buy | Buy |
| Sep 29, 2026 | Goldman Sachs | Initiated | — | Buy |
| Sep 22, 2026 | BTIG | Maintained | Buy | Buy |
| Aug 4, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Jul 30, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Jul 30, 2026 | TD Cowen | Maintained | Buy | Buy |
| Jul 30, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jul 30, 2026 | BTIG | Maintained | Buy | Buy |
| Jul 9, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Jun 29, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jun 17, 2026 | BTIG | Reiterated | Buy | Buy |
| May 12, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| May 6, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| May 6, 2026 | TD Cowen | Maintained | Buy | Buy |
| May 6, 2026 | Guggenheim | Reiterated | Buy | Buy |
| May 6, 2026 | BTIG | Reiterated | Buy | Buy |
| Feb 6, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Feb 6, 2026 | BTIG | Maintained | Buy | Buy |
| Jan 26, 2026 | Guggenheim | Maintained | Buy | Buy |
| Nov 11, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Nov 6, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Nov 6, 2025 | BTIG | Maintained | Buy | Buy |
| Oct 22, 2025 | BTIG | Maintained | Buy | Buy |
| Oct 15, 2025 | Piper Sandler | Maintained | Overweight | Overweight |
| Oct 13, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Sep 30, 2025 | Guggenheim | Initiated | — | Buy |
| Aug 6, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Aug 6, 2025 | TD Cowen | Maintained | Buy | Buy |